Winship Cancer Institute of Emory University received renewal of the Comprehensive Cancer Center designation from NCI.
NCI and all five cooperative groups that make up the National Clinical Trials Network have launched a large-scale precision medicine initiative that will match cancer patients with early-phase clinical trials testing novel drug combinations that target specific tumor alterations.
Peng Mao, assistant professor in the Department of Internal Medicine, Division of Molecular Medicine at UNM Comprehensive Cancer Center, was awarded a NCI grant totaling $1.6 million over five years for research into the “Mechanism of Transcription-coupled DNA Repair and its Impact on Cancer Mutations.”
Atlantic Health System’s Atlantic Health BioBank partnered with NCI’s Cooperative Human Tissue Network Southern Division. The collaboration between Atlantic Health System and NCI will help provide clinical researchers with the resources they need to advance the science of medicine.
As Case Comprehensive Cancer Center’s new director, and on behalf of our membership, I applaud the Biden administration for tapping Monica Bertagnolli, MD, FASCO, as the second female director of the National Institutes of Health (NIH) and congratulate Dr. Bertagnolli on her candidacy.
Hong-yu Li, a researcher with the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, recently received a five-year, $3.19 million grant from NCI to work toward advancing therapeutic treatments for certain types of cancer.
ImmunityBio Inc. and NCI are partnering to open a clinical trial to study ImmunityBio’s investigational Tri-Ad5 vaccine combination (Adenovirus 5 CEA/MUC1/brachyury) together with its IL-15 superagonist N-803, an immune-enhancer, for people with Lynch syndrome.
If you saw Monica Bertagnolli dash around at the Orlando convention center at the annual meeting of the American Association for Cancer Research earlier this week, you would not have guessed that these may be her final days in the NCI director’s job.
Cancer death rates will need to drop faster—by an average of 2.7% per year versus the current rate of 2.3% per year—to achieve the Cancer Moonshot goal of a 50% reduction by 2047.
This point is easily overlooked: Monica Bertagnolli has two jobs, not one. She is the director of the National Cancer Institute and head of the National Cancer Program.